Inhaltsbereich
| 443 Einträge | 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 › » |
Seite 1 / 23
 Druckansicht
|
| NOX4-driven ROS formation mediates PTP inactivation and cell transformation in FLT3ITD positive AML cells. |
| Jayavelu AK, Müller JP, Bauer R, Böhmer SA, Lässig J, Cerny-Reiterer S, Sperr WR, Valent P, Maurer B, Moriggl R, Schröder K, Shah AM, Fischer M, Scholl S, Barth J, Oellerich T, Berg T, Serve H, Frey S, Fischer T, Heidel FH, Böhmer FD |
| Leukemia. 2015 Aug 26. pii: leu2015234. doi: 10.1038/leu.2015.234 |
| PMID: 26308771 |
| Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemia. |
| Wedeh G, Cerny-Reiterer S, Eisenwort G, Herrmann H, Blatt K, Hadzijusufovic E, Sadovnik I, Müllauer L, Schwaab J, Hoffmann T, Bradner JE, Radia D, Sperr WR, Hoermann G, Reiter A, Horny HP, Zuber J, Arock M, Valent P |
| Leukemia. 2015 Jun 9. pii: leu2015138. doi: 10.1038/leu.2015.138 |
| PMID: 26055303 |
| Prominin-1 (CD133, AC133) and dipeptidyl-peptidase IV (CD26) are indicators of infinitive growth in colon cancer cells. |
| Grunt TW, Hebar A, Laffer S, Wagner R, Peter B, Herrmann H, Graf A, Bilban M, Posch M, Hoermann G, Mayerhofer M, Eisenwort G, Zielinski CC, Selzer E, Valent P |
| American journal of cancer research. 2015 Jan 15. pmc: PMC4396035 |
| PMID: 25973297 |
| Cancer stem cells in basic science and in translational oncology: can we translate into clinical application? |
| Schulenburg A, Blatt K, Cerny-Reiterer S, Sadovnik I, Herrmann H, Marian B, Grunt TW, Zielinski CC, Valent P |
| Journal of hematology & oncology. 2015 Feb 25. doi: 10.1186/s13045-015-0113-9. pii: 10.1186/s13045-015-0113-9. pmc: PMC4345016 |
| PMID: 25886184 |
| Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q. |
| Heuser M, Meggendorfer M, Cruz MM, Fabisch J, Klesse S, Köhler L, Göhring G, Ganster C, Shirneshan K, Gutermuth A, Cerny-Reiterer S, Krönke J, Panagiota V, Haferlach C, Koenecke C, Platzbecker U, Thiede C, Schroeder T, Kobbe G, Ehrlich S, Stamer K, Döhner K, Valent P, Schlegelberger B, Kroeger N, Ganser A, Haase D, Haferlach T, Thol F |
| Leukemia. 2015 Feb 24. pii: leu201549. doi: 10.1038/leu.2015.49 |
| PMID: 25792355 |
| Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM). |
| Della Porta MG, Tuechler H, Malcovati L, Schanz J, Sanz G, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Cermak J, Fonatsch C, Le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski J, Magalhaes SM, Miyazaki Y, Pfeilstöcker M, Sekeres MA, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, Germing U, Haase D, Greenberg PL, Cazzola M |
| Leukemia. 2015 Feb 27. pii: leu201555. doi: 10.1038/leu.2015.55 |
| PMID: 25721895 |
| KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis. |
| Arock M, Sotlar K, Akin C, Broesby-Olsen S, Hoermann G, Escribano L, Kristensen TK, Kluin-Nelemans HC, Hermine O, Dubreuil P, Sperr WR, Hartmann K, Gotlib J, Cross NC, Haferlach T, Garcia-Montero A, Orfao A, Schwaab J, Triggiani M, Horny HP, Metcalfe DD, Reiter A, Valent P |
| Leukemia. 2015 Feb 4. pii: leu201524. doi: 10.1038/leu.2015.24. pmc: PMC4522520. mid: EMS64251 |
| PMID: 25650093 |
| Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia. |
| Cerny-Reiterer S, Rabenhorst A, Stefanzl G, Herndlhofer S, Hoermann G, Müllauer L, Baumgartner S, Beham-Schmid C, Sperr WR, Mannhalter C, Sill H, Linkesch W, Arock M, Hartmann K, Valent P |
| Oncotarget. 2015 Mar 5. pii: 3074. pmc: PMC4413638 |
| PMID: 25605011 |
| Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event. |
| Jawhar M, Schwaab J, Schnittger S, Sotlar K, Horny HP, Metzgeroth G, Müller N, Schneider S, Naumann N, Walz C, Haferlach T, Valent P, Hofmann WK, Cross NC, Fabarius A, Reiter A |
| Leukemia. 2015 Jan 8. pii: leu20154. doi: 10.1038/leu.2015.4 |
| PMID: 25567135 |
| Chronic mast cell leukemia: a novel leukemia-variant with distinct morphological and clinical features. |
| Valent P, Sotlar K, Sperr WR, Reiter A, Arock M, Horny HP |
| Leukemia research. 2014 Sep 30. pii: S0145-2126(14)00292-6. doi: 10.1016/j.leukres.2014.09.010 |
| PMID: 25443885 |
| DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia. |
| Valent P, Sadovnik I, Ráčil Z, Herrmann H, Blatt K, Cerny-Reiterer S, Eisenwort G, Lion T, Holyoake T, Mayer J |
| European journal of clinical investigation. 2014 Dec 2. doi: 10.1111/eci.12368 |
| PMID: 25371066 |
| Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control group. |
| Braulke F, Platzbecker U, Müller-Thomas C, Götze K, Germing U, Brümmendorf TH, Nolte F, Hofmann WK, Giagounidis AA, Lübbert M, Greenberg PL, Bennett JM, Solé F, Mallo M, Slovak ML, Ohyashiki K, Le Beau MM, Tüchler H, Pfeilstöcker M, Nösslinger T, Hildebrandt B, Shirneshan K, Aul C, Stauder R, Sperr WR, Valent P, Fonatsch C, Trümper L, Haase D, Schanz J |
| Haematologica. 2014 Oct 24. pii: haematol.2014.110452. doi: 10.3324/haematol.2014.110452 |
| PMID: 25344522 |
| Inhibition of STAT5: a therapeutic option in BCR-ABL1-driven leukemia. |
| Berger A, Sexl V, Valent P, Moriggl R |
| Oncotarget. 2014 Nov 11. pii: 2465. pmc: PMC4259420 |
| PMID: 25333255 |
| Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells. |
| Veigel D, Wagner R, Stübiger G, Wuczkowski M, Filipits M, Horvat R, Benhamú B, López-Rodríguez ML, Leisser A, Valent P, Grusch M, Hegardt FG, García J, Serra D, Auersperg N, Colomer R, Grunt TW |
| International journal of cancer. Journal international du cancer. 2014 Nov 3. doi: 10.1002/ijc.29261 |
| PMID: 25302649 |
| Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage. |
| Valent P, Berger J, Cerny-Reiterer S, Peter B, Eisenwort G, Hoermann G, Müllauer L, Mannhalter C, Steurer M, Bettelheim P, Horny HP, Arock M |
| Annals of hematology. 2014 Sep 11. doi: 10.1007/s00277-014-2207-9 |
| PMID: 25209843 |
| The serum tryptase test: an emerging robust biomarker in clinical hematology. |
| Valent P, Sperr WR, Sotlar K, Reiter A, Akin C, Gotlib J, Horny HP, Arock M |
| Expert review of hematology. 2014 Aug 28. doi: 10.1586/17474086.2014.955008 |
| PMID: 25169217 |
| Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS. |
| Porwit A, van de Loosdrecht AA, Bettelheim P, Brodersen LE, Burbury K, Cremers E, Della Porta MG, Ireland R, Johansson U, Matarraz S, Ogata K, Orfao A, Preijers F, Psarra K, Subirá D, Valent P, van der Velden VH, Wells D, Westers TM, Kern W, Béné MC |
| Leukemia. 2014 Jun 12. pii: leu2014191. doi: 10.1038/leu.2014.191 |
| PMID: 24919805 |
| Identification of campath-1 (CD52) as novel drug target in neoplastic stem cells in 5q-patients with MDS and AML. |
| Blatt K, Herrmann H, Hoermann G, Willmann M, Cerny-Reiterer S, Sadovnik I, Herndlhofer S, Streubel B, Rabitsch W, Sperr WR, Mayerhofer M, Rülicke T, Valent P |
| Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 May 5. pii: 1078-0432.CCR-13-2811. doi: 10.1158/1078-0432.CCR-13-2811 |
| PMID: 24799522 |
| Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia. |
| Herrmann H, Sadovnik I, Cerny-Reiterer S, Rülicke T, Stefanzl G, Willmann M, Hoermann G, Bilban M, Blatt K, Herndlhofer S, Mayerhofer M, Streubel B, Sperr WR, Holyoake TL, Mannhalter C, Valent P |
| Blood. 2014 Apr 28. pii: blood-2013-10-536078. doi: 10.1182/blood-2013-10-536078 |
| PMID: 24778155 |
| CD52 is a molecular target in advanced systemic mastocytosis. |
| Hoermann G, Blatt K, Greiner G, Putz EM, Berger A, Herrmann H, Cerny-Reiterer S, Gleixner KV, Walz C, Hoetzenecker K, Müllauer L, Reiter A, Sotlar K, Sexl V, Valent P, Mayerhofer M |
| FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2014 Apr 23. pii: fj.14-250894. doi: 10.1096/fj.14-250894 |
| PMID: 24760752 |
| 443 Einträge | 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 › » |
Seite 1 / 23
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
